# Interparfums share price today (Interparfums, Inc., IPAR)

> Interparfums, Inc.'s P/E is near the low end of its own history, higher than only 24% of past readings, and its quarterly results are still getting worse. IPAR · Consumer Staples · Household & Personal Products · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/ipar

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Growing steadily, from the last 12 quarters
- Price: $117.09 (+31.3% in a year)
- P/E: 22.4× (lower than 76% of the last 4.6 years)
- Revenue (Jun 2026): $341 M (+2.1% on a year ago)
- Profit (Jun 2026): $30.5 M (−4.7% on a year ago)
- Operating margin: 12.3% (−5.4 points on a year ago)
- ROE: 15%, FY25
- ROIC: 18.4%, against a 10.4% cost of capital: +8.0 points

The main question: the share price moved +31.3% in a year while yearly earnings per share moved +2.3%. The difference came from the market paying a higher multiple. ## What is the Interparfums share price today? Interparfums, Inc.'s share price was $117.09 at the close on 3 November 2026. It has been rising for 3 weeks. That is 11.7% above its average price over the last 200 trading days. In the last 52 weeks it traded between $81 and $125, and at that close it sat 83% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 6 weeks running. Over the last 10 years the share price moved +319% while the S&P 500 moved +255%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 25 September 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Interparfums pay? Interparfums, Inc. paid $3.20 per share over the last four reported quarters. The most recent declaration was $0.80 for Jun 2026. At today's price of $117.09 that is a yield of 2.73%, based on dividends already paid, not a forecast. ## Which stock lists is Interparfums on? Interparfums is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Interparfums profitable? Interparfums, Inc. earned $30.5 M of net profit in the Jun 2026 quarter, −4.7% on the same quarter a year earlier. Full-year FY25 profit was $168 M. Over 4 years profit has grown 17.8% a year on average. That is 8.9% of the quarter's revenue. The same quarter a year earlier earned $32.0 M. For the full year, FY25 profit was $168 M (+2.5% on the year before). Why profit moved: revenue changed +2.1% on a year earlier and the margin moved −5.4 percentage points. Sales did the work while the margin got thinner. On average over the last four quarters, profit changed +4.8% and revenue +3.0%. Profit and revenue are moving at about the same pace. ## How much revenue does Interparfums make, and is it growing? Interparfums, Inc. reported $341 M of revenue in the Jun 2026 quarter, +2.1% on the same quarter a year earlier. That is the 4th quarter in a row with growth on the year before. Over 4 years it has grown 14.1% a year on average. The last full year, FY25, came in at $1.5 B. The last four reported quarters add to $1.5 B. FY25 revenue was $1.5 B, +2.5% on the year before. Recent pace: the last four quarters grew +3.0% on average, against 14.1% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +2.9%, against +5.0% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +4.2%, against +8.9% a year (rolling over). ## How much of every $100 of sales does Interparfums keep? Interparfums, Inc.'s operating margin was 12.3% in the Jun 2026 quarter, 5.4 percentage points lower than the same quarter a year ago. Across 5 years it has been between 17.1% and 19.2%. The latest quarter is below every full year in that period. Why the margin moved: operating margin changed −5.4 percentage points on the year while gross margin changed −3.4 points. So the drop came mostly from the gross margin, which means input costs and prices charged. ## Is Interparfums' profit turning into cash? Over the last 3 years, 105% of Interparfums, Inc.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $215 M of operating cash against $168 M of profit. After $24.4 M of spending on assets, $190 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Interparfums' cash go? Interparfums, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $35.6 M on assets over the last 3 years. Averaged over those years that is 0.8% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $35.6 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Interparfums' P/E ratio, and how does it compare with its own history? Interparfums, Inc.'s P/E is 22.4×, near the low end of its own history: it has been lower only 24% of the time. Its usual P/E (the middle reading) is 26.2×, over 4.6 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved +2.3% while the price moved +31.3%. The price did better than earnings, which pushed the multiple up within its own range. Where the price move came from: over 3 years the price moved −3.4% a year; about +1.8% a year came from earnings growth and about −5.2 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Interparfums business getting better or worse? Interparfums, Inc.'s business is growing steadily. Revenue, profit and EPS growth have stayed positive throughout, and ROCE is steady at 20.7%. This is based on 12 quarters of 4 measures. Why it matters: steady growth with healthy returns is how a business compounds over time. ## How much does Interparfums earn on its capital? Interparfums, Inc. earned a ROE of 15% in FY25. That is up from a low of 12% in FY21. Its return on capital used (ROIC) is 8.0 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 11.3% net margin and 0.94× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 11.3% net margin × 0.94× asset turnover × 1.44× leverage (assets divided by equity) ≈ 15.3% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 18.4% − 10.4% = +8.0 percentage points. The 10.4% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. A gap this wide means each dollar put back into the business creates more than a dollar of value. The 18.4% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at 21.7%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Interparfums have too much debt? Interparfums, Inc. has total debt of $165 M against shareholder equity of $1.1 B as of Jun 2026, so its debt is 0.15× its equity, which is very little. Year by year, that ratio went from 0.25 in FY21 to 0.19 in FY25. So the returns on this page come from the business, not from borrowed money. ## What is the Interparfums shareholding pattern? 10.8% of Interparfums, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so a large group of traders is betting against it. At normal trading volumes, closing those positions would take about 8.4 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Interparfums from balance-sheet trouble? For Interparfums, Inc., the Z-score is 7.65. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 7.65 is well clear of the danger zone, so the balance sheet is not the risk here. ## How does Interparfums rank in its industry? 52.4 out of 100, rank 7 of 20 in Household & Personal Products, with 81% of the evidence available. Interparfums, Inc. scores 52.4 out of 100 against the 20 companies it is compared with in Household & Personal Products, ranking 7. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 13.9 + 17.9 + 9.7 + 10.9 = 52.4. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Interparfums compared with? Interparfums ranks 7 of 20 Household & Personal Products companies on the 4-Factor Sector Score, with 52.4 out of 100. 1. [Kenvue Inc.](https://www.sectoralpha.in/us/stocks/kvue) KVUE · Evidence leans up · 61% evidence 63.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 27.7/43.75 · Revenue 1.8% · Profit 16.9% · Operating margin change -0.4 points · 83% evidence Capital efficiency 21.1/31.25 · ROCE 14.4% · Operating margin 19.4% · 76% evidence Valuation 15.1/25 · P/E 22.2× · PEG 1.37 · 65% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 27.7 + 21.1 + 15.1 = 63.9 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: There is no relative-strength reading for this week, so the score is built from earnings, capital efficiency and valuation alone. 2. [Church & Dwight Co., Inc.](https://www.sectoralpha.in/us/stocks/chd) CHD · turning · Evidence leans up · 81% evidence 61.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.6/35 · Revenue 2.7% · Profit 41.9% · Operating margin change -2.7 points · 83% evidence Capital efficiency 15.8/25 · ROCE 14.6% · Operating margin 18.1% · 76% evidence Valuation 14.3/20 · P/E 30.8× · PEG 0.66 · 65% evidence Relative strength 13.1/20 · Lead over its industry 1.3% · Lead over S&P 500 8.7% · 1 year 25.7% · 100% evidence · 2 of 12 weeks ahead Exact sum: 18.6 + 15.8 + 14.3 + 13.1 = 61.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [The Estée Lauder Companies Inc.](https://www.sectoralpha.in/us/stocks/el) EL · leader · Evidence leans up · 64% evidence 59.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.7/35 · Revenue 5% · Profit n/a · Operating margin change 2.7 points · 62% evidence Capital efficiency 11.0/25 · ROCE 12.3% · Operating margin 7% · 76% evidence Valuation 11.5/20 · P/E -104.7× · PEG n/a · 15% evidence Relative strength 13.2/20 · Lead over its industry 0% · Lead over S&P 500 6.7% · 1 year 20.1% · 100% evidence · 12 of 12 weeks ahead Exact sum: 23.7 + 11 + 11.5 + 13.2 = 59.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [The Procter & Gamble Company](https://www.sectoralpha.in/us/stocks/pg) PG · turning · Evidence leans up · 85% evidence 58.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.7/35 · Revenue 3.5% · Profit -4.4% · Operating margin change 0.3 points · 95% evidence Capital efficiency 21.2/25 · ROCE 24.6% · Operating margin 27.1% · 76% evidence Valuation 6.7/20 · P/E 21.4× · PEG 2.4 · 65% evidence Relative strength 10.5/20 · Lead over its industry -3.3% · Lead over S&P 500 3.7% · 1 year 10.3% · 100% evidence · 3 of 12 weeks ahead Exact sum: 19.7 + 21.2 + 6.7 + 10.5 = 58.1 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value. 5. [Colgate-Palmolive Company](https://www.sectoralpha.in/us/stocks/cl) CL · turning · Evidence leans up · 81% evidence 56.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.2/35 · Revenue 5.2% · Profit -29.2% · Operating margin change 0.1 points · 83% evidence Capital efficiency 21.1/25 · ROCE 40.8% · Operating margin 21% · 76% evidence Valuation 7.7/20 · P/E 36× · PEG 2.18 · 65% evidence Relative strength 8.1/20 · Lead over its industry -3.6% · Lead over S&P 500 3.4% · 1 year 21.4% · 100% evidence · 0 of 12 weeks ahead Exact sum: 19.2 + 21.1 + 7.7 + 8.1 = 56.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Acme United Corporation](https://www.sectoralpha.in/us/stocks/acu) ACU · leader · Evidence leans up · 81% evidence 53.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.8/35 · Revenue 9.3% · Profit -9.1% · Operating margin change -0.9 points · 83% evidence Capital efficiency 10.9/25 · ROCE 8.7% · Operating margin 10.9% · 76% evidence Valuation 6.7/20 · P/E 18.5× · PEG 2.5 · 65% evidence Relative strength 19.1/20 · Lead over its industry 28% · Lead over S&P 500 36.8% · 1 year 88.7% · 100% evidence · 12 of 12 weeks ahead Exact sum: 16.8 + 10.9 + 6.7 + 19.1 = 53.5 · What this means: Relative strength against the index is 36.8%, and revenue and profit growth are weak. 7. Interparfums, Inc. this page IPAR · quiet · Evidence leans up · 81% evidence 52.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.9/35 · Revenue 2.9% · Profit 4.4% · Operating margin change -5.4 points · 83% evidence Capital efficiency 17.9/25 · ROCE 21% · Operating margin 12.3% · 76% evidence Valuation 9.7/20 · P/E 21.4× · PEG 1.99 · 65% evidence Relative strength 10.9/20 · Lead over its industry 3% · Lead over S&P 500 10.3% · 1 year 34% · 100% evidence · 5 of 12 weeks ahead Exact sum: 13.9 + 17.9 + 9.7 + 10.9 = 52.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Kimberly-Clark Corporation](https://www.sectoralpha.in/us/stocks/kmb) KMB · basing · Evidence leans up · 81% evidence 50.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.1/35 · Revenue 0.7% · Profit -18.9% · Operating margin change 2.8 points · 83% evidence Capital efficiency 20.6/25 · ROCE 24.6% · Operating margin 19% · 76% evidence Valuation 7.6/20 · P/E 18.6× · PEG 2.38 · 65% evidence Relative strength 5.2/20 · Lead over its industry -10% · Lead over S&P 500 -3.6% · 1 year 0.6% · 100% evidence · 2 of 12 weeks ahead Exact sum: 17.1 + 20.6 + 7.6 + 5.2 = 50.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Newell Brands Inc.](https://www.sectoralpha.in/us/stocks/nwl) NWL · losing its lead · Evidence leans up · 64% evidence 50.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.3/35 · Revenue -2% · Profit n/a · Operating margin change 5.2 points · 62% evidence Capital efficiency 8.6/25 · ROCE 7.3% · Operating margin 14.7% · 76% evidence Valuation 11.0/20 · P/E -11.8× · PEG n/a · 15% evidence Relative strength 11.4/20 · Lead over its industry 8.6% · Lead over S&P 500 16% · 1 year 77.6% · 100% evidence · 7 of 12 weeks ahead Exact sum: 19.3 + 8.6 + 11 + 11.4 = 50.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [Helen of Troy Limited](https://www.sectoralpha.in/us/stocks/hele) HELE · turning · Evidence leans down · 67% evidence 49.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 14.8/35 · Revenue 0.3% · Profit n/a · Operating margin change -2.6 points · 71% evidence Capital efficiency 9.4/25 · ROCE 9.8% · Operating margin 0.5% · 76% evidence Valuation 10.7/20 · P/E -7.1× · PEG n/a · 15% evidence Relative strength 14.3/20 · Lead over its industry 13.8% · Lead over S&P 500 22.2% · 1 year 52.3% · 100% evidence · 2 of 12 weeks ahead Exact sum: 14.8 + 9.4 + 10.7 + 14.3 = 49.2 · What this means: Relative strength against the index is 22.2%, and revenue and profit growth are weak. 11. [e.l.f. Beauty, Inc.](https://www.sectoralpha.in/us/stocks/elf) ELF · leader · Evidence leans down · 81% evidence 48.7 out of 100 Growth Capital Valuation Relative
12. [Spectrum Brands Holdings, Inc.](https://www.sectoralpha.in/us/stocks/spb) SPB · quiet · Evidence leans down · 81% evidence 45.1 out of 100 Growth Capital Valuation Relative
13. [Coty Inc.](https://www.sectoralpha.in/us/stocks/coty) COTY · breaking out · Evidence leans down · 64% evidence 44.3 out of 100 Growth Capital Valuation Relative
14. [Edgewell Personal Care Company](https://www.sectoralpha.in/us/stocks/epc) EPC · turning · Evidence leans down · 71% evidence 41.6 out of 100 Growth Capital Valuation Relative
15. [Magnera Corporation](https://www.sectoralpha.in/us/stocks/magn) MAGN · quiet · Evidence leans down · 64% evidence 39.4 out of 100 Growth Capital Valuation Relative
16. [The Clorox Company](https://www.sectoralpha.in/us/stocks/clx) CLX · basing · Evidence leans down · 81% evidence 38.4 out of 100 Growth Capital Valuation Relative
17. [The Honest Company, Inc.](https://www.sectoralpha.in/us/stocks/hnst) HNST · losing its lead · Evidence leans down · 71% evidence 35.0 out of 100 Growth Capital Valuation Relative
18. [Nu Skin Enterprises, Inc.](https://www.sectoralpha.in/us/stocks/nus) NUS · basing · Most evidence points down · 71% evidence 30.6 out of 100 Growth Capital Valuation Relative
19. [Oddity Tech Ltd.](https://www.sectoralpha.in/us/stocks/odd) ODD · breaking out · Most evidence points down · 81% evidence 24.7 out of 100 Growth Capital Valuation Relative
20. [Unilever PLC](https://www.sectoralpha.in/us/stocks/ul) UL · turning · Too little evidence to rank firmly · 47% evidence 50.1 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Household & Personal Products](https://www.sectoralpha.in/us/sectors/household-personal-products), all 20 compared on one page. ## Which companies are close to Interparfums in size? Interparfums is the 10th largest of 22 Household & Personal Products companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Church & Dwight Co., Inc., The Clorox Company and e.l.f. Beauty, Inc. Just below it: Coty Inc., Newell Brands Inc. and Spectrum Brands Holdings, Inc. ### Household & Personal Products companies close in size

1. [Church & Dwight Co., Inc.](https://www.sectoralpha.in/us/stocks/chd) $25.8 billion
2. [The Clorox Company](https://www.sectoralpha.in/us/stocks/clx) $11.3 billion
3. [e.l.f. Beauty, Inc.](https://www.sectoralpha.in/us/stocks/elf) $6.6 billion
4. Interparfums, Inc. $3.7 billion
5. [Coty Inc.](https://www.sectoralpha.in/us/stocks/coty) $2.9 billion
6. [Newell Brands Inc.](https://www.sectoralpha.in/us/stocks/nwl) $2.4 billion
7. [Spectrum Brands Holdings, Inc.](https://www.sectoralpha.in/us/stocks/spb) $2 billion

[All 22 Household & Personal Products companies, largest first](https://www.sectoralpha.in/us/sectors/household-personal-products#all-companies)

### Companies close in size in other industries

1. [DHT Holdings, Inc.](https://www.sectoralpha.in/us/stocks/dht) $3.8 billion · Oil & Gas Midstream
2. [Otter Tail Corporation](https://www.sectoralpha.in/us/stocks/ottr) $3.8 billion · Conglomerates
3. Interparfums, Inc. $3.8 billion
4. [Cohen & Steers, Inc.](https://www.sectoralpha.in/us/stocks/cns) $3.8 billion · Asset Management
5. [Lazard, Inc.](https://www.sectoralpha.in/us/stocks/laz) $3.8 billion · Capital Markets

## What else do people ask about Interparfums? ### What were Interparfums's latest quarterly results? Interparfums, Inc. reported revenue of $341 M and net profit of $30.5 M for the Jun 2026 quarter. Revenue rose 2.1% and profit fell 4.7% compared with a year earlier. Earnings per share were $0.95. The operating margin was 12.3%, 5.4 percentage points lower than a year earlier (as of 3 November 2026). ### What is Interparfums's market cap? Interparfums, Inc.'s market capitalisation is $3.7 B at a stock price of $117.09. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Interparfums performing? Interparfums, Inc.'s share price has been rising for 3 weeks. In its latest quarter, revenue rose 2.1% and profit fell 4.7% compared with a year earlier. Over the past 13 weeks it has done worse than the S&P 500, for 6 weeks running (as of 3 November 2026). ### Will Interparfums's stock price go up? This page does not forecast Interparfums, Inc.'s stock price. What it shows instead: the stock price is $117.09, and it has been rising for 3 weeks. Its P/E of 22.4× is higher than 24% of its own last 5 years (as of 3 November 2026). ### Where is Interparfums in its business cycle? Interparfums, Inc.'s FY25 operating margin was 18.2%, against a 5-year range of 17.1% to 19.2%: the middle of its own range, neither a peak nor a low. The latest quarter was 12.3%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Interparfums story? The main question: the share price moved +31.3% in a year while yearly earnings per share moved +2.3%. The difference came from the market paying a higher multiple. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Interparfums a stock worth studying right now? What the numbers show: Interparfums, Inc.'s P/E is near the low end of its own history, higher than only 24% of past readings, and its quarterly results are still getting worse. The main open question: whether earnings grow into a price that has already moved. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.